(PharmaNewsWire.Com, February 24, 2017 ) Minimally invasive surgeries involve smaller incisions, lower risks of infection, and shorter recovery time. Thin needles and an endoscope to visually guide the surgery are used during these surgeries. In most procedures, a surgeon makes several small incisions and inserts thin tubes called trocars into the body. Carbon dioxide is then used to inflate the area to create space between the internal organs and the skin. Next, a miniature camera is inserted through one of the trocars in order to view the procedure on video monitors in the operating room. Other specialized instruments are inserted through the other trocars in order to perform the surgery after that.
Reduced expenses, blood loss, skin scar, duration of hospital stay, and trauma to the patient are some advantages of minimally invasive surgeries. Continual innovation in the field of minimally invasive surgery makes it useful for various procedures. Closing of atrial septal defect, appendicectomy, biopsy, inguinal hernia repairs, removal of pituitary tumor, removal of kidney and ureteric calculi, carpal tunnel release, and repair of thoracic and abdominal aneurysm are some of the procedures performed using minimally invasive surgery. This type of surgery is not suitable for all patients owing to factors such as raised body mass index, skin adhesions, and other medical conditions. Risks and complications of anesthesia, bleeding, infection, thromboembolic disease, shoulder pain due to carbon dioxide insufflation, and injury to organs are some of the complications associated with minimally invasive surgery. Trocar, retractors, staplers, laproscope, arthroscope, scissors, and forceps are some of the major instruments used in these surgeries. These instruments are used in exploratory surgery, laproscopic surgery, and arthroscopic surgery.
North America dominates the global market for minimally invasive surgical instruments due to rising number of minimally invasive surgeries and growing geriatric population in the region. This market is expected to show high growth rates in the next five years in Asia, with China and India being the fastest growing markets in the Asia-Pacific region. The key driving forces of the minimally invasive surgical instruments market in developing countries are the large pool of patients, increasing awareness about minimally invasive surgery techniques, improving healthcare infrastructure, increasing purchasing power of the middle class population, and rising government funding in the region.
Increasing number of surgeries among the geriatric population, increasing minimally invasive surgeries over traditional open surgery, reduced healthcare cost and time associated with minimally invasive surgery, increase in healthcare expenditure, increasing awareness about healthcare, and rising number of initiatives by various governments and government associations are some of the key factors driving the growth of the global minimally invasive surgical instruments market. However, complex regulatory frameworks, lack of skilled surgeons, and absence of reimbursement in medical device industry are major restraint on the growth of the global minimally invasive surgical instruments market.
Growing obesity rate and increasing awareness about technologically advanced minimally invasive surgical instruments and procedures would help develop opportunities for the global minimally invasive surgical instruments market.
The major companies operating in the global minimally invasive surgical instruments market are Medtronic Plc, Aesculap, Inc., Stryker Corporation, Smith & Nephew Plc, Ethicon, Inc., Abbott Laboratories, Inc., Applied Medicals, Conmed Corporation, and Zimmer Holdings, Inc.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
